TY - JOUR
T1 - Highly potent nociceptin analog containing the Arg-Lys triple repeat
AU - Okada, Kazushi
AU - Sujaku, Tetsujo
AU - Chuman, Yoshiro
AU - Nakashima, Rie
AU - Nose, Takeru
AU - Costa, Tommaso
AU - Yamada, Yoshinari
AU - Yokoyama, Masayuki
AU - Nagahisa, Atsushi
AU - Shimohigashi, Yasuyuki
PY - 2000/11/19
Y1 - 2000/11/19
N2 - One of the structural characteristics of a neuropeptide nociceptin is the existence of Arg-Lys (RK) residues at positions 8-9 and 12-13; both RKs have been suggested to bind to the acidic amino acid cluster in the second extracellular loop of the seven transmembrane domain receptor ORL1. With a design strategy of attempting to obtain an analog that binds more strongly to the receptor's acidic cluster, we synthesized a series of nociceptin analogs in which the RK dipeptide unit was placed at positions 6-7, 10-11, or 14-15 adjacent to the parent RKs. Among these nociceptin analogs containing the RK triple repeat, [ArgLys6-7]- and [Arg-Lys10-11]nociceptins exhibited weak activities (6-9 and 60-90% of nociceptin, respectively) both in the receptor binding assay and in the [35S]GTPγS binding functional assay. In contrast, [Arg-Lys14-15]nociceptin was found to be very potent in both assays (3-fold in binding and 17-fold in GTPγS functional assay). [Arg-Lys14-15]nociceptin was the first peptide analog found to be stronger than the parent nociceptin, and structure-activity studies have suggested that the incorporated Arg-Lys14-15 interacts with either the receptor acidic amino acid cluster or the receptor aromatic amino acid residues. (C) 2000 Academic Press.
AB - One of the structural characteristics of a neuropeptide nociceptin is the existence of Arg-Lys (RK) residues at positions 8-9 and 12-13; both RKs have been suggested to bind to the acidic amino acid cluster in the second extracellular loop of the seven transmembrane domain receptor ORL1. With a design strategy of attempting to obtain an analog that binds more strongly to the receptor's acidic cluster, we synthesized a series of nociceptin analogs in which the RK dipeptide unit was placed at positions 6-7, 10-11, or 14-15 adjacent to the parent RKs. Among these nociceptin analogs containing the RK triple repeat, [ArgLys6-7]- and [Arg-Lys10-11]nociceptins exhibited weak activities (6-9 and 60-90% of nociceptin, respectively) both in the receptor binding assay and in the [35S]GTPγS binding functional assay. In contrast, [Arg-Lys14-15]nociceptin was found to be very potent in both assays (3-fold in binding and 17-fold in GTPγS functional assay). [Arg-Lys14-15]nociceptin was the first peptide analog found to be stronger than the parent nociceptin, and structure-activity studies have suggested that the incorporated Arg-Lys14-15 interacts with either the receptor acidic amino acid cluster or the receptor aromatic amino acid residues. (C) 2000 Academic Press.
UR - http://www.scopus.com/inward/record.url?scp=0034687553&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034687553&partnerID=8YFLogxK
U2 - 10.1006/bbrc.2000.3822
DO - 10.1006/bbrc.2000.3822
M3 - Article
C2 - 11097863
AN - SCOPUS:0034687553
VL - 278
SP - 493
EP - 498
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
SN - 0006-291X
IS - 2
ER -